NEOSTIGMINE METHYLSULFATE
Active substance: neostigmine methylsulfate
INJECTION · NEOSTIGMINE METHYLSULFATE .5 mg/mL
United StatesActive
Marketing holder: Amphastar Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- NEOSTIGMINE METHYLSULFATE · .5 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-276a-7643-8b2d-2a5d00f7572e,01a1208c-2772-7a46-9d8a-7a32b88e0659,01a1208c-2ea4-7eee-b1d2-cd5f5edb4d76,01a1208c-5047-712a-b52b-ba75ba856e0a,01a1208c-7720-7a3b-b704-c6a68928ac45;count=50 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0548-9601
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 0548-9601 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0548-9601 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0548-9601 · Verified 2026-10-09 · open in source